| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 |
| filingDate |
1993-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1994-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3de76ce262e0a231508637d10b2b9df9 |
| publicationDate |
1994-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5344829-A |
| titleOfInvention |
Use of OB-101 to treat inflammation |
| abstract |
A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of inflammation in both the anterior and posterior portions of the eye, as well as in other parts of the body. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013059841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1375489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004014792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1375489-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007105911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007238758-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383894-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8354439-B2 |
| priorityDate |
1991-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |